Max Wolf

3.0k total citations
55 papers, 2.1k citations indexed

About

Max Wolf is a scholar working on Pathology and Forensic Medicine, Oncology and Genetics. According to data from OpenAlex, Max Wolf has authored 55 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Pathology and Forensic Medicine, 23 papers in Oncology and 19 papers in Genetics. Recurrent topics in Max Wolf's work include Lymphoma Diagnosis and Treatment (32 papers), Chronic Lymphocytic Leukemia Research (16 papers) and Viral-associated cancers and disorders (16 papers). Max Wolf is often cited by papers focused on Lymphoma Diagnosis and Treatment (32 papers), Chronic Lymphocytic Leukemia Research (16 papers) and Viral-associated cancers and disorders (16 papers). Max Wolf collaborates with scholars based in Australia, United Kingdom and Netherlands. Max Wolf's co-authors include John F. Seymour, H. Miles Prince, Richard Klasa, Robert Marcus, Eva Kimby, Anton Hagenbeek, Marinus H. J. van Oers, M. van Glabbeke, Andrej Vranovský and Harald Holte and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

Max Wolf

55 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Max Wolf Australia	22	1.7k	1.0k	791	490	302	55	2.1k
Liliana Devizzi Italy	22	1.5k 0.9×	960 0.9×	478 0.6×	456 0.9×	161 0.5×	59	1.9k
Andreas Lohri Switzerland	24	2.1k 1.2×	1.5k 1.4×	735 0.9×	723 1.5×	314 1.0×	69	2.8k
Monica Tani Italy	26	1.7k 1.0×	819 0.8×	453 0.6×	509 1.0×	459 1.5×	105	2.2k
Judy Sutherland Canada	9	1.8k 1.0×	1.1k 1.0×	628 0.8×	539 1.1×	182 0.6×	11	2.0k
Catherine Sebban France	24	2.3k 1.4×	1.8k 1.7×	862 1.1×	575 1.2×	332 1.1×	68	3.0k
Annarita Conconi Italy	24	1.9k 1.1×	1.0k 1.0×	701 0.9×	550 1.1×	125 0.4×	71	2.3k
Karamjit Gill Canada	13	2.4k 1.4×	1.6k 1.5×	859 1.1×	636 1.3×	234 0.8×	19	2.9k
Lorena Appio Italy	4	1.3k 0.8×	885 0.8×	404 0.5×	405 0.8×	285 0.9×	8	1.7k
Vincent Delwail France	23	2.1k 1.2×	1.1k 1.0×	1.3k 1.6×	1.1k 2.3×	214 0.7×	78	2.6k
Annalisa Chiappella Italy	23	1.3k 0.8×	782 0.7×	487 0.6×	506 1.0×	221 0.7×	111	1.7k

Countries citing papers authored by Max Wolf

Since Specialization

Citations

This map shows the geographic impact of Max Wolf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Max Wolf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Max Wolf more than expected).

Fields of papers citing papers by Max Wolf

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Max Wolf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Max Wolf. The network helps show where Max Wolf may publish in the future.

Co-authorship network of co-authors of Max Wolf

This figure shows the co-authorship network connecting the top 25 collaborators of Max Wolf. A scholar is included among the top collaborators of Max Wolf based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Max Wolf. Max Wolf is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wang, Eugene, et al.. (2023). Abdominal pain secondary to bilateral adrenal haemorrhage as the first presentation of antiphospholipid syndrome. The Medical Journal of Australia. 218(6). 250–251. 1 indexed citations

Lasica, Masa, Abbey Willcox, Kate Burbury, et al.. (2019). The effect of tyrosine kinase inhibitor interruption and interferon use on pregnancy outcomes and long-term disease control in chronic myeloid leukemia. Leukemia & lymphoma. 60(7). 1796–1802. 15 indexed citations

Hertzberg, Mark, Jane Matthews, Janey M. Stone, et al.. (2014). A phase III randomized trial of high‐dose CEOP + filgrastim versus standard‐dose CEOP in patients with non‐Hodgkin lymphoma: 10‐year follow‐up data: Australasian Leukaemia and Lymphoma Group (ALLG) NHL07 trial. American Journal of Hematology. 89(5). 536–541. 8 indexed citations

Cheah, Chan Y., Michael S. Hofman, Michael Dickinson, et al.. (2013). Limited role for surveillance PET–CT scanning in patients with diffuse large B-cell lymphoma in complete metabolic remission following primary therapy. British Journal of Cancer. 109(2). 312–317. 50 indexed citations

Wirth, Andrew, Andrew Grigg, Max Wolf, et al.. (2011). Risk and response adapted therapy for early stage Hodgkin lymphoma: a prospective multicenter study of the Australasian Leukaemia and Lymphoma Group/Trans-Tasman Radiation Oncology Group. Leukemia & lymphoma. 52(5). 786–795. 1 indexed citations

Oers, Marinus H. J. van, Evelyn Tönnissen, M. van Glabbeke, et al.. (2010). BCL-2/IgH Polymerase Chain Reaction Status at the End of Induction Treatment Is Not Predictive for Progression-Free Survival in Relapsed/Resistant Follicular Lymphoma: Results of a Prospective Randomized EORTC 20981 Phase III Intergroup Study. Journal of Clinical Oncology. 28(13). 2246–2252. 34 indexed citations

Grigg, Andrew, Janey M. Stone, Alvin Milner, et al.. (2010). Phase II study of autologous stem cell transplant using busulfan–melphalan chemotherapy-only conditioning followed by interferon for relapsed poor prognosis follicular non-Hodgkin lymphoma. Leukemia & lymphoma. 51(4). 641–649. 2 indexed citations

Peinert, Stefan, Constantine S. Tam, H. Miles Prince, et al.. (2010). Fludarabine based combinations are highly effective as first-line or salvage treatment in patients with Waldenström macroglobulinemia. Leukemia & lymphoma. 51(12). 2188–2197. 12 indexed citations

Gill, Saar, Kirsten Herbert, H. Miles Prince, et al.. (2009). Mantle cell lymphoma with central nervous system involvement: frequency and clinical features. British Journal of Haematology. 147(1). 83–88. 40 indexed citations

10.

Gill, Saar, Max Wolf, H. Miles Prince, et al.. (2008). [18F]Fluorodeoxyglucose Positron Emission Tomography Scanning for Staging, Response Assessment, and Disease Surveillance in Patients with Mantle Cell Lymphoma. Clinical Lymphoma & Myeloma. 8(3). 159–165. 37 indexed citations

11.

Oers, Marinus H. J. van, Richard Klasa, Robert Marcus, et al.. (2006). Rituximab maintenance improves clinical outcome of relapsed/resistant follicular non-Hodgkin lymphoma in patients both with and without rituximab during induction: results of a prospective randomized phase 3 intergroup trial. Blood. 108(10). 3295–3301. 432 indexed citations

12.

Tam, Constantine S., Max Wolf, H. Miles Prince, et al.. (2006). Fludarabine, cyclophosphamide, and rituximab for the treatment of patients with chronic lymphocytic leukemia or indolent non‐hodgkin lymphoma. Cancer. 106(11). 2412–2420. 75 indexed citations

13.

Tam, Constantine S., Max Wolf, David Westerman, et al.. (2005). Fludarabine Combination Therapy Is Highly Effective in First-Line and Salvage Treatment of Patients with Waldenström's Macroglobulinemia. Clinical Lymphoma & Myeloma. 6(2). 136–139. 28 indexed citations

14.

Thomas, Wayne, Roger G. Owen, Peter Hillmen, et al.. (2005). Superior quality and duration of responses among patients with mantle-cell lymphoma treated with fludarabine and cyclophosphamide with or without rituximab compared with prior responses to CHOP. Leukemia & lymphoma. 46(4). 549–552. 22 indexed citations

15.

Tam, Constantine S., Max Wolf, E. Januszewicz, et al.. (2004). A new model for predicting infectious complications during fludarabine‐based combination chemotherapy among patients with indolent lymphoid malignancies. Cancer. 101(9). 2042–2049. 22 indexed citations

16.

Joshua, Doug, et al.. (1994). Peripheral Blood Lymphocyte Surface Antigen Expression and Prognosis in Myeloma: Australian Leukaemia Study Group Study. Leukemia & lymphoma. 14(3-4). 303–309. 4 indexed citations

17.

Wolf, Max, et al.. (1993). Adult T cell leukaemia lymphoma in a non‐Aboriginal Australian woman with no apparent risk factors. The Medical Journal of Australia. 158(7). 486–487. 2 indexed citations

18.

Bishop, James F., et al.. (1992). A randomised trial of dexamethasone, lorazepam and prochlorperazine for emesis in patients receiving chemotherapy. European Journal of Cancer. 28(1). 47–50. 8 indexed citations

19.

Bishop, James F., et al.. (1991). Etoposide in leukemia. Cancer. 67(S1). 285–291. 11 indexed citations

20.

Wolf, Max. (1955). USE OF ROTARY PUNCHES FOR SKIN BIOPSY. Archives of Dermatology. 71(5). 640–640. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact